ADWIA

ADWIA Pharmaceuticals is a leading Egyptian company recognized for its expertise in veterinary medicine. The company specializes in producing high-quality medications tailored for animal health, addressing a wide range of therapeutic needs across various animal species. Leveraging its state-of-the-art facility in the 10th of Ramadan City, licensed by the Egyptian Drug Authority, ADWIA ensures that all veterinary products meet stringent quality standards.

ADWIA’s veterinary portfolio includes a diverse range of antibiotics designed to treat both hospital-acquired and community-acquired infections in animals, ensuring comprehensive antimicrobial coverage. In addition, the company provides treatments for central nervous system (CNS) disorders in animals, contributing to the management of conditions affecting animal health and welfare.

The company has built a strong reputation for delivering veterinary solutions that meet the evolving needs of the global market. Through its established presence in both domestic and international markets, including the Gulf Cooperation Council (GCC) countries, the Commonwealth of Independent States (CIS) regions, and various African nations, ADWIA plays a pivotal role in enhancing access to quality veterinary care worldwide.

Guided by a vision of innovation and excellence, ADWIA remains dedicated to advancing animal health by developing and supplying effective, safe, and high-quality veterinary products. With a team of dedicated professionals and a commitment to continuous improvement, the company is well-positioned to support the veterinary industry and contribute to the well-being of animals in the regions it serves.

ADWIA's leadership emphasizes the importance of remaining at the forefront of industry advancements and trends, striving to bring innovative veterinary treatments to market. This commitment to excellence and customer satisfaction has established ADWIA as a trusted partner among veterinarians and animal health professionals globally. As it moves forward, the company continues to focus on expanding its reach and impact, aiming to redefine the future of veterinary healthcare and make a lasting contribution to animal welfare.